Stem cell therapy of tendinopathies: Suggestions from veterinary medicine

Muscles, Ligaments and Tendons Journal

Volumn 2, Issue 3, 2012, Pages 187-192

  Muttini, Aurelio ^a,c   Salini, Vincenzo ^b,c   Valbonetti, Luca ^a,c   Abate, Michele ^b,c  

^a UNIVERSITY OF TERAMO   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c StemTeCh Group   (Italy)

Author keywords

Achilles tendon; Stem cells; Tendinopathy

Indexed keywords

EID: 84892887018     PISSN: None     EISSN: 22404554     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Barboni B, Russo V, Curini V et al. Achilles tendon regeneration can be improved by amniotic epithelial cells allotransplantation. Cell Transplant 2012.
2. Abate M, Silbernagel KG, Siljeholm C et al. Pathogenesis of tendinopathies: inflammation or degeneration? Arthritis Res Ther 2009;11(3):235.
3. Abate M, Oliva F, Schiavone C, Salini V. Achilles tendinopathy in amateur runners: role of adiposity (Tendinopathies and obesity). MLTJ 2012; 2(1):44-48.
4. Thorpe CT, Clegg PD, Birch HL. A review of tendon injury: why is the equine superficial digital flexor tendon most at risk? Equine Vet J 2010 Mar;42(2):174-180.
5. Longo UG, Loppini M, Denaro L, Maffulli N, Denaro V. Conservative management of patients with an osteoporotic vertebral fracture: a review of the literature. J Bone Joint Surg Br 2012;94(2):152-157.
6. Dowling BA, Dart AJ, Hodgson DR, Smith RK. Superficial digital flexor tendonitis in the horse. Equine Vet J 2000;32(5):369-378.
7. Salini V, Abate M. Percutaneous steroidal treatment in relapses of chronic tendinopathies: a pilot study. Int J Immunopathol Pharmacol 2011;24(1):211-216.
8. Wilkins R, Bisson LJ. Operative versus nonoperative management of acute achilles tendon ruptures: a quantitative systematic review of randomized controlled trials. Am J Sports Med 2012;40(9):2154-2160.
9. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 1968;6(2):230-247.
10. Ryan JM, Barry FP, Murphy JM, Mahon BP. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2005; 26;2:8.
11. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003;31(10):890-896.
12. Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007; 25(11):2896-2902.
13. Priya N, Sarcar S, Majumdar AS, Sundarraj S. Explant culture: a simple, reproducible, efficient and economic technique for isolation of mesenchymal stromal cells from human adipose tissue and lipoaspirate. J Tissue Eng Regen Med 2012; 27:1-9.
14. Stillwell C, Wang F, Xiang B, et al. Adipose tissue houses different subtypes of stem cells. Can J Physiol Pharmacol 2012;90(9):1295-1301.
15. Blaber SP, Webster RA, Hill CJ, et al. Analysis of in vitro secretion profiles from adipose-derived cell populations. J Transl Med 2012;22;10(1):172.
16. Lovati AB, Corradetti B, Lange Consiglio A et al. Characterization and differentiation of equine tendon-derived progenitor cells. J Biol Regul Homeost Agents 2011;25(2 Suppl):S75-84.
17. Zhou Z, Akinbiyi T, Xu L, et al. Tendon-derived stem/progenitor cell aging: defective self-renewal and altered fate. Aging Cell 2010;9(5):911-915.
18. Saito S, Sawai K, Minamihashi A, Ugai H, Murata T, Yokoyama KK. Derivation, maintenance, and induction of the differentiation in vitro of equine embryonic stem cells. Methods Mol Biol 2006;329:59-79.
19. Chen SS, Fitzgerald W, Zimmerberg J, Kleinman HK, Margolis L. Cell-cell and cell-extracellular matrix interactions regulate embryonic stem cell differentiation. Stem Cells 2007;25(3):553-561.
20. Evangelista M, Soncini M, Parolini O. Placenta-derived stem cells: new hope for cell therapy? Cytotechnology 2008;58(1):33-42.
21. Iacono E, Brunori L, Pirrone A et al. Isolation, characterization and differentiation of mesenchymal stem cells from amniotic fluid, umbilical cord blood and Wharton's jelly in the horse. Reproduction 2012;143(4):455-468.
22. Miki T, Lehmann T, Cai H, Stolz DB, Strom SC. Stem cell characteristics of amniotic epithelial cells. Stem Cells 2005;23(10):1549-1559.
23. Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod 2007;77(3):577-588.
24. Parolini O, Alviano F, Bagnara GP et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 2008;26(2):300-311.
25. Lange-Consiglio A, Corradetti B et al. Characterization and potential applications of progenitor-like cells isolated from horse amniotic membrane. J Tissue Eng Regen Med 2012;6(8):622-635.
26. Mattioli M, Gloria A, Turriani M et al. Stemness characteristics and osteogenic potential of sheep amniotic epithelial cells. Cell Biol Int 2012;36(1):7-19.
27. Parolini O, Soncini M, Evangelista M, Schmidt D. Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen Med 2009;4:275-291.
28. Bailo M, Soncini M, Vertua E et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 2004 27;78(10):1439-1448.
29. Hori J, Wang M, Kamiya K, Takahashi H, Sakuragawa N. Immunological characteristics of amniotic epithelium. Cornea 2006;25(10 Suppl 1):S53-8.
30. Hunt JS, Petroff MG, McIntire RH, Ober C. HLA-G and immune tolerance in pregnancy. FASEB J 2005;19(7):681-693.
31. Tamagawa T, Ishiwata I, Saito S. Establishment and characterization of a pluripotent stem cell line derived from human amniotic membranes and initiation of germ layers in vitro. Hum Cell 2004;17(3):125-130.
32. Muttini A, Mattioli M, Petrizzi L et al. Experimental study on allografts of amniotic epithelial cells in calcaneal tendon lesions of sheep. Vet Res Commun 2010;34 Suppl 1:S117-120.
33. Butler DL, Juncosa-Melvin N, Boivin GP et al. Functional tissue engineering for tendon repair: A multidisciplinary strategy using mesenchymal stem cells, bioscaffolds, and mechanical stimulation. J Orthop Res 2008;26(1):1-9.
34. Uysal CA, Tobita M, Hyakusoku H, Mizuno H. Adipose-derived stem cells enhance primary tendon repair: Biomechanical and immunohistochemical evaluation. J Plast Reconstr Aesthet Surg 2012 6.
35. Behfar M, Sarrafzadeh-Rezaei F, Hobbenaghi R, Delirezh N, Dalir-Naghadeh B. Enhanced mechanical properties of rabbit flexor tendons in response to intratendinous injection of adipose derived stromal vascular fraction. Curr Stem Cell Res Ther 2012;7(3):173-178.
36. Kasashima Y, Takahashi T, Smith RK et al. Prevalence of superficial digital flexor tendonitis and suspensory desmitis in Japanese Thoroughbred flat racehorses in 1999. Equine Vet J 2004;36(4):346-350.
37. Ely ER, Avella CS, Price JS, Smith RK, Wood JL, Verheyen KL. Descriptive epidemiology of fracture, tendon and suspensory ligament injuries in National Hunt racehorses in training. Equine Vet J 2009;41(4):372-378.
38. Smith RK, Birch HL, Goodman S, Heinegård D, Goodship AE. The influence of ageing and exercise on tendon growth and degeneration-hypotheses for the initiation and prevention of strain-induced tendinopathies. Comp Biochem Physiol A Mol Integr Physiol 2002;133(4):1039-1050.
39. Dahlgren LA, Mohammed HO, Nixon AJ. Temporal expression of growth factors and matrix molecules in healing tendon lesions. J Orthop Res 2005;23(1):84-92.
40. Bi Y, Ehirchiou D, Kilts TM et al. Identification of tendon stem/progenitor cells and the role of the extracellular matrix in their niche. Nat Med 2007;13(10):1219-1227.
41. Nixon AJ, Dahlgren LA, Haupt JL, Yeager AE, Ward DL. Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenaseinduced tendinitis. Am J Vet Res 2008;69(7):928-937.
42. Crovace A, Lacitignola L, Rossi G, Francioso E. Histological and immunohistochemical evaluation of autologous cultured bone marrow mesenchymal stem cells and bone marrow mononucleated cells in collagenase-induced tendinitis of equine superficial digital flexor tendon. Vet Med Int 2010;2010:250978.
43. Caniglia CJ, Schramme MC, Smith RK. The effect of intralesional injection of bone marrow derived mesenchymal stem cells and bone marrow supernatant on collagen fibril size in a surgical model of equine superficial digital flexor tendonitis. Equine Vet J 2012;44(5):587-593.
44. O'Meara B, Bladon B, Parkin TD, Fraser B, Lischer CJ. An investigation of the relationship between race performance and superficial digital flexor tendonitis in the Thoroughbred racehorse. Equine Vet J 2010;42(4):322-326.
45. Godwin EE, Young NJ, Dudhia J, Beamish IC, Smith RK. Implantation of bone marrow-derived mesenchymal stem cells demonstrates improved outcome in horses with overstrain injury of the superficial digital flexor tendon. Equine Vet J 2012;44(1):25-32.
46. Marfe G, Rotta G, De Martino L et al. A new clinical approach: use of blood-derived stem cells (BDSCs) for superficial digital flexor tendon injuries in horses. Life Sci 2012 6;90(21-22):825-830.
47. Fulton IC, MacLean AA, O'Rielly JL, Church S. Superior check ligament desmotomy for treatment of superficial digital flexor tendonitis in thoroughbred and standardbred horses. Aust Vet J 1994;71(8):233-235.
48. Gibson KT, Burbidge HM, Pfeiffer DU. Superficial digital flexor tendonitis in thoroughbred race horses: outcome following non-surgical treatment and superior check desmotomy. Aust Vet J 1997;75(9):631-635.
49. Muttini A, Valbonetti L, Abate M et al. Ovine amniotic epithelial cells: In vitro characterization and transplantation into equine superficial digital flexor tendon spontaneous defects. Res Vet Sci 2012 Sep 3.
50. Ahmad Z, Wardale J, Brooks R, Henson F, Noorani A, Rushton N. Exploring the application of stem cells in tendon repair and regeneration. Arthroscopy 2012;28(7):1018-1029.